Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Phase 1/2 Completed 12 enrolled Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Heffter Research Institute · collab

RandomizedSingle-groupQuadruple-blindTreatment

Summary

Psychiatric Research Study For Cancer Patients The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.

Timeline

Start: 2004-04
Primary completion: 2008-12
Completion: 2008-12

Publications

Results Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011 Jan;68(1):71-8. doi: 10.1001/archgenpsychiatry.2010.116. Epub 2010 Sep 6.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Psilocybin	Other / unclassified	0.2 mg/kg	—

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Summary

Timeline

Publications

Drugs

Indications